Innovus Pharmaceuticals Inc (INNV1)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Employees:
27
9171 TOWNE CENTRE DRIVE, SUITE 440, SAN DIEGO, CA 92122
858-964-5123

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

N/A

Data derived from most recent annual or quarterly report
Market Cap 3.21 Million Shares Outstanding2.61 Million Avg 30-day Volume 21.31 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.81
Price to Revenue0.2556 Debt to Equity-1.6608 EBITDA-5.715 Million
Price to Book Value0.0 Operating Margin-25.2784 Enterprise Value8.166 Million
Current Ratio0.498 EPS Growth0.561 Quick Ratio0.123
1 Yr BETA -7.8171 52-week High/Low 0.0 / Profit Margin-35.8466
Operating Cash Flow Growth62.4247 Altman Z-Score-7.1791 Free Cash Flow to Firm -1.783 Million
View SEC Filings from INNV1 instead.

View recent insider trading info

Funds Holding INNV1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding INNV1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Events (8k)

  • 8-K: filed on 2020-02-14:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2019-09-18:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-07-24:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2019-07-22:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-06-19:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-05-31:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-05-30:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2019-05-15:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-04-19:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-04-11:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    DAMATO NICOLE CHIEF LEGAL OFFICER

    • Officer
    24,880 2021-09-14 1

    WELSH, CARSON, ANDERSON & STOWE XII, L.P.

    WCAS CO-INVEST ASSOCIATES LLC

    WELSH, CARSON, ANDERSON & STOWE XII DELAWARE, L.P.

    WELSH, CARSON, ANDERSON & STOWE XII DELAWARE II, L.P.

    WELSH, CARSON, ANDERSON & STOWE XII CAYMAN, L.P.

    WCAS XII CO-INVESTORS LLC

    WCAS MANAGEMENT CORP

    WCAS - CO-INVEST HOLDCO, L.P.

    WCAS XII ASSOCIATES LLC

    WCAS XII ASSOCIATES CAYMAN, L.P.

    • 10% Owner
    116,520,612 2021-03-03 0

    TRAYNOR SEAN

    • Director
    0 2021-03-03 0

    ZORETIC RICHARD C

    • Director
    0 2021-03-03 0

    TAVENNER MARILYN B

    • Director
    0 2021-03-03 0

    BUSH JOHN ELLIS

    • Director
    0 2021-03-03 0

    SCULLY THOMAS

    • Director
    0 2021-03-03 0

    CAVANNA ANDREW J

    • Director
    0 2021-03-03 0

    KENNEDY EDWARD MOORE JR.

    • Director
    0 2021-03-03 0

    IGNITE AGGREGATOR LP

    APAX X (GUERNSEY) USD AIV LP

    IGNITE GP INC.

    APAX X EUR L.P.

    APAX X USD L.P.

    APAX X GP CO. LTD

    • 10% Owner
    116,520,612 2021-03-03 0

    TCO GROUP HOLDINGS, L.P.

    • 10% Owner
    116,520,612 2021-03-03 0

    DECHERT CAROLINE

    • Director
    0 2021-03-03 0

    MAHESH PAVITHRA

    • Director
    0 2021-03-03 0

    HEWITT MAUREEN CEO, PRESIDENT AND DIRECTOR

    • Officer
    • Director
    0 2021-03-03 0

    LOZZANO MARIA CORPORATE COO

    • Officer
    0 2021-03-03 0

    DOERR ROBIN CHIEF SALES AND MKTG. OFFICER

    • Officer
    0 2021-03-03 0

    WELCH MELISSA CHIEF MEDICAL OFFICER

    • Officer
    0 2021-03-03 0

    GUTIERREZ BARBARA CHIEF FINANCIAL OFFICER

    • Officer
    0 2021-03-03 0

    ARMISTICE CAPITAL, LLC

    ARMISTICE CAPITAL MASTER FUND LTD.

    BOYD STEVEN

    • 10% Owner
    No longer subject to file 2020-02-14 0

    LIU VIVIAN H

    • Director
    0 2020-01-02 0

    MIRZA ZIAD

    • Director
    0 2020-01-02 0

    NUHAILY DEAN

    • Director
    0 2020-01-02 0

    ESBER HENRY JEMIL

    • Director
    0 2019-07-01 0

    BERHOLTZ RANDY EVP, CORPORATE DEVELOPMENT

    0 2018-04-05 0

    GUTIERREZ RAULY VICE PRESIDENT, FINANCE

    0 2018-02-23 0

    SELHORN RYAN J VP, CFO

    0 2017-04-27 0

    NOVALERE HOLDINGS, LLC

    • 10% Owner
    25,617,592 2016-11-30 0

    DAMAJ BASSAM CHIEF EXECUTIVE OFFICER

    0 2016-11-16 0

    HOFFMAN ROBERT CHIEF FINANCIAL OFFICER

    280,103 2016-09-06 0

    DILLEN LYNNETTE EVP, CFO

    0 2015-03-31 0

    BROWN MORGAN R SEE REMARKS

    • Officer
    0 2013-05-28 0

    BARTHOLOMEW JACKI

    • Director
    0 2008-02-28 0

    HARKNESS THOMAS L SECRETARY

    • Officer
    • Director
    0 2008-02-28 0

    BOYACK WALLACE PRESIDENT & CEO

    • Officer
    • Director
    • 10% Owner
    8,405,788 2008-02-21 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    INNOVAGE HOLDING CORP INNV 2021-09-24 22:15:03 UTC -0.2234 0.2934 250000
    INNOVAGE HOLDING CORP INNV 2021-09-24 21:45:03 UTC -0.2234 0.2934 250000
    INNOVAGE HOLDING CORP INNV 2021-09-24 21:15:03 UTC -0.2234 0.2934 250000
    INNOVAGE HOLDING CORP INNV 2021-09-24 20:45:03 UTC -0.2234 0.2934 250000
    INNOVAGE HOLDING CORP INNV 2021-09-24 20:15:03 UTC -0.2234 0.2934 250000
    INNOVAGE HOLDING CORP INNV 2021-09-24 19:45:03 UTC -0.2234 0.2934 250000
    INNOVAGE HOLDING CORP INNV 2021-09-24 19:15:03 UTC -0.2234 0.2934 250000
    INNOVAGE HOLDING CORP INNV 2021-09-24 18:45:03 UTC -0.2234 0.2934 250000
    INNOVAGE HOLDING CORP INNV 2021-09-24 18:15:03 UTC -0.2234 0.2934 250000
    INNOVAGE HOLDING CORP INNV 2021-09-24 17:45:03 UTC -0.2234 0.2934 250000
    INNOVAGE HOLDING CORP INNV 2021-09-24 17:15:03 UTC -0.2234 0.2934 250000
    INNOVAGE HOLDING CORP INNV 2021-09-24 16:45:03 UTC -0.2325 0.3025 250000
    INNOVAGE HOLDING CORP INNV 2021-09-24 16:15:03 UTC -0.2325 0.3025 250000
    INNOVAGE HOLDING CORP INNV 2021-09-24 15:45:03 UTC -0.2325 0.3025 250000
    INNOVAGE HOLDING CORP INNV 2021-09-24 15:15:04 UTC -0.2325 0.3025 250000
    INNOVAGE HOLDING CORP INNV 2021-09-24 14:45:02 UTC -0.2126 0.2826 250000
    INNOVAGE HOLDING CORP INNV 2021-09-24 14:15:02 UTC -0.2126 0.2826 250000
    INNOVAGE HOLDING CORP INNV 2021-09-24 13:45:02 UTC -0.2126 0.2826 250000
    INNOVAGE HOLDING CORP INNV 2021-09-24 13:15:03 UTC -0.2126 0.2826 250000
    INNOVAGE HOLDING CORP INNV 2021-09-24 12:45:03 UTC -0.2126 0.2826 250000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    Elevate your investments